H-group (homology)
5069.1 Transmembrane heme-binding four-helical bundle
Ligands and drugs
4,310
Member domains
810
with ligand contacts (≤ 4 Å)
18.8% of members
600
with DrugDomain annotations
13.9% of members
582
with a DrugBank compound
13.5% of members
Aggregated over all current member domains of this group. Drug annotations come from DrugDomain; buffers and crystallization additives are excluded from the tables below.
Chemical profile
Chemical profiles are computed for X-groups. 5069.1 belongs to X-group 5069 Transmembrane heme-binding four-helical bundle, which binds 7.6 ligand superclasses per 20 proteins, narrower than 50% of the 256 X-groups with enough proteins to compare. View its chemical profile →
DrugBank compounds
| DrugBank | PDB ligand | Name | Domains |
|---|---|---|---|
| DB18267 | HEM | Ferroheme | 501 |
| DB03429 | CDL | Tetrastearoyl cardiolipin | 132 |
| DB03047 | EPH | L-Alpha-Phosphatidyl-Beta-Oleoyl-Gamma-Palmitoyl-Phosphatidylethanolamine | 69 |
| DB04327 | PEE | Phosphatidylethanolamine | 69 |
| DB03317 | HEC | Ferroheme C | 43 |
| DB04657 | CBE | Carboxin | 36 |
| DB02133 | CLA | Chlorophyll A | 25 |
| DB02686 | UMQ | Undecyl-Beta-D-Maltopyranoside | 23 |
| DB02182 | HEB | Hybrid Between B and C Type Hemes (Protoporphyrin Ixcontaining Fe) | 22 |
| DB06755 | BCR | Beta carotene | 21 |
| DB09270 | U10 | Ubidecarenone | 21 |
| DB08690 | UQ2 | Ubiquinone Q2 | 19 |
| DB03152 | BGL | B-2-Octylglucoside | 16 |
| DB13075 | MQ7 | Menaquinone 7 | 15 |
| DB01728 | PEF | 1,2-dihexadecanoyl-sn-glycero-3-phosphoethanolamine | 14 |
| DB04631 | AT5 | Atpenin A5 | 12 |
| DB08689 | UQ1 | Ubiquinone Q1 | 11 |
| DB07349 | AGA | (1S)-2-{[{[(2S)-2,3-DIHYDROXYPROPYL]OXY}(HYDROXY)PHOSPHORYL]OXY}-1-[(PENTANOYLOXY)METHYL]ETHYL OCTANOATE | 8 |
| DB07778 | FMX | (S)-famoxadone | 8 |
| DB09114 | PCF | Colfosceril palmitate | 8 |
Most frequently bound compounds
| PDB ligand | Name | Domains in contact |
|---|---|---|
| HEM | PROTOPORPHYRIN IX CONTAINING FE | 700 |
| CDL | CARDIOLIPIN | 261 |
| 3PE | 1,2-Distearoyl-sn-glycerophosphoethanolamine | 105 |
| PEE | 1,2-dioleoyl-sn-glycero-3-phosphoethanolamine | 100 |
| PC1 | 1,2-DIACYL-SN-GLYCERO-3-PHOSPHOCHOLINE | 93 |
| EPH | L-ALPHA-PHOSPHATIDYL-BETA-OLEOYL-GAMMA-PALMITOYL-PHOSPHATIDYLETHANOLAMINE | 69 |
| SMA | STIGMATELLIN A | 61 |
| U10 | UBIQUINONE-10 | 60 |
| UQ6 | 5-(3,7,11,15,19,23-HEXAMETHYL-TETRACOSA-2,6,10,14,18,22-HEXAENYL)-2,3-DIMETHOXY-6-METHYL-BENZENE-1,4-DIOL | 51 |
| MQ9 | MENAQUINONE-9 | 47 |
| UNL | Unknown ligand | 42 |
| PTY | PHOSPHATIDYLETHANOLAMINE | 39 |
| HEC | HEME C | 38 |
| CBE | 2-METHYL-N-PHENYL-5,6-DIHYDRO-1,4-OXATHIINE-3-CARBOXAMIDE | 37 |
| 9YF | (2R)-2-(hexadecanoyloxy)-3-{[(S)-hydroxy{[(1R,2R,3R,4R,5R,6S)-2,3,4,5,6-pentahydroxycyclohexyl]oxy}phosphoryl]oxy}propyl (9S)-9-methyloctadecanoate | 34 |
| LOP | (1R)-2-{[(R)-(2-AMINOETHOXY)(HYDROXY)PHOSPHORYL]OXY}-1-[(DODECANOYLOXY)METHYL]ETHYL (9Z)-OCTADEC-9-ENOATE | 33 |
| CLA | CHLOROPHYLL A | 32 |
| HDD | CIS-HEME D HYDROXYCHLORIN GAMMA-SPIROLACTONE | 31 |
| UQ | Coenzyme Q10, (2Z,6E,10Z,14E,18E,22E,26Z)-isomer | 30 |
| UMQ | UNDECYL-MALTOSIDE | 29 |